The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling-Reference-Cited by-同舟云学术

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling

Published:2013-03-10 Issue:4 Volume:227 Page:711-725
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Wierońska Joanna M.,Acher Francine C.,Sławińska Anna,Gruca Piotr,Łasoń-Tyburkiewicz Magdalena,Papp Mariusz,Pilc Andrzej

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s00213-013-3005-0/fulltext.html

Reference66 articles.

1. Acher FC, Tellier FJ, Azerad R, Brabet IN, Fagni L, Pin JP (1997) Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes. J Med Chem 40(19):3119–3129

2. Acher F, Selvam C, Triballeau N, Pin JP, Bertrand HO (2007) Hypo-phosphorous acid derivatives and their therapeutical applications. U.S. Patent Application WO2007052169

3. Ago Y, Koyama Y, Baba A, Matsuda T (2003) Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45(8):1050–1056

4. Allen AR, Singh A, Zhuang ZP, Kung MP, Kung HF, Lucki I (1997) The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors. Pharmacol Biochem Behav 57(1–2):301–307

5. Alphs L, Benedetti F, Fleischhacker WW, Kane JM (2012) Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? Int J Neuropsychopharmacol 15(7):1003–1014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Innovative Pharmacological Targets in Schizophrenia;Current Treatment Options in Psychiatry;2024-07-13

2. Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review);International Journal of Molecular Medicine;2023-11-28

3. Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset;Psychopharmacology;2023-07-29

4. New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties;Journal of Enzyme Inhibition and Medicinal Chemistry;2021-12-11

5. A new class of 5-HT1A receptor antagonists with procognitive and antidepressant properties;Future Medicinal Chemistry;2021-09